scispace - formally typeset
Open AccessJournal ArticleDOI

Implications of the COVID-19 pandemic for people with bipolar disorders: A scoping review.

Reads0
Chats0
TLDR
In this paper, the impact of the COVID-19 pandemic on people with severe mental illnesses, including bipolar disorder (BD), remains unclear, warranting scoping review on the matter.
About
This article is published in Journal of Affective Disorders.The article was published on 2021-12-01 and is currently open access. It has received 26 citations till now. The article focuses on the topics: Systematic review & Psychological intervention.

read more

Citations
More filters
Journal ArticleDOI

The post COVID-19 healthcare landscape and the use of long-acting injectable antipsychotics for individuals with schizophrenia and bipolar I disorder: the importance of an integrated collaborative-care approach

TL;DR: The impact of the COVID-19 pandemic on the mental healthcare landscape and use of LAIs for individuals with schizophrenia or bipolar I disorder (BP-I) was discussed in a roundtable discussion as mentioned in this paper .
Journal ArticleDOI

Remote mental health care interventions during the COVID-19 pandemic: An umbrella review

TL;DR: A systematic search for systematic reviews and meta-analyses was conducted up to August 12, 2022, and 38 systematic reviews were identified as mentioned in this paper , which examined what the impact of COVID-19 was on access and delivery of mental health services and how mental health service have changed during the pandemic.
Journal ArticleDOI

Suicidality in clinically stable bipolar disorder and schizophrenia patients during the COVID-19 pandemic

TL;DR: In this paper , the authors examined the one-year prevalence of suicidal ideation (SI), suicide plans (SP), and suicide attempts (SA) in bipolar disorder (BD) and schizophrenia (SCZ) patients during the COVID-19 pandemic.
Journal ArticleDOI

Clinical Aspects of Manic Episodes After SARS-CoV-2 Contagion or COVID-19

TL;DR: This review highlights the importance of a now widespread viral disease as a potential agent unmasking and exacerbating bipolar mood disorder, and it can hopefully help physicians in establishing a rapid diagnosis and treatment, and pave the road for future research on neuroinflammation triggered by SARS-CoV-2.
References
More filters
Journal ArticleDOI

PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation

TL;DR: A PRISMA extension for scoping reviews was needed to provide reporting guidance for this specific type of knowledge synthesis and was developed according to published guidance by the EQUATOR (Enhancing the QUAlity and Transparency of health Research) Network for the development of reporting guidelines.
Journal ArticleDOI

A scoping review on the conduct and reporting of scoping reviews

TL;DR: In this article, the authors conducted a scoping review to identify papers that utilized and/or described Scoping review methods; guidelines for reporting Scoping reviews; and studies that assessed the quality of reporting of scoping reviews.
Journal ArticleDOI

The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness

Joseph Firth, +56 more
TL;DR: This Commission summarises advances in understanding on the topic of physical health in people with mental illness, and presents clear directions for health promotion, clinical care, and future research.
Journal ArticleDOI

Digital Mental Health and COVID-19: Using Technology Today to Accelerate the Curve on Access and Quality Tomorrow

TL;DR: In this article, the authors argue that now is the time to accelerate and bend the curve on digital health and discuss the need for workforce training, high-quality evidence, and digital equity among other factors critical for bending the curve further.
Journal ArticleDOI

Increased risk of COVID-19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States

TL;DR: Individuals with a recent diagnosis of a mental disorder are identified as being at increased risk for COVID‐19 infection, which is further exacerbated among African Americans and women, and as having a higher frequency of some adverse outcomes of the infection.